Quantity | = | Concentration | x | Volume | x | Molecular Weight |
---|---|---|---|---|---|---|
= | x | x |
1) Click the Molarity Calculation Cart® button.
2) Specify the Concentration and Volume of your desired Molarity.
3) Click Calculate.
4) Your desired Quantity will be calculated and will be put under Quantity: (only for mg)
5) Click Add to Cart and then Proceed to checkout to complete the order. You will receive the quantity as you ordered as solvent-free form.
Alert: If you want to make a solution with a solvent (such DMSO), please add instructions in the notes section (such as 10 nM/1 mL in DMSO) and we will pack and deliver the product as a solution (such as 10 nM solution in 1 mL DMSO). If the product cannot be dissolved in DMSO or you would like to specify your own preferred solvent, please add detailed instructions in the notes section. All solutions must be shipped with an ice bag, costing an additional fee of $20 for S&H.
AOB13608
Chemical Name: SP2043; LRRFSTAPFAFIDINDVINF; Leu-Arg-Arg-Phe-Ser-Thr-Ala-Pro-Phe-Ala-Phe-Ile-Asp-Ile-Asn-Asp-Val-Ile-Asn-Phe 3 TFA salt
In stock
Warning: Last items in stock!
Availability date:
Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
---|---|---|---|
1 | 100 | $76.05 | Total: $7,605.00 |
1 | 50 | $87.88 | Total: $4,394.00 |
1 | 25 | $103.09 | Total: $2,577.25 |
1 | 10 | $121.68 | Total: $1,216.80 |
1 | 5 | $143.65 | Total: $718.25 |
Molecular Formula | C117H169F9N28O35 |
Molecular Weight | 2698.79 |
Storage Condition | 0°C (short term), -20°C (long term), desiccated |
Solubility | DMSO |
Purity | 98% by HPLC |
Synonym | SP2043; LRRFSTAPFAFIDINDVINF; Leu-Arg-Arg-Phe-Ser-Thr-Ala-Pro-Phe-Ala-Phe-Ile-Asp-Ile-Asn-Asp-Val-Ile-Asn-Phe 3 TFA salt |
Type IV collagen-derived peptide, inhibiting the activation of multiple growth factor receptors, including many related to both angiogenesis and lymphangiogensis (ie. VEGFR2 and VEGFR3), inhibiting the growth of a primary triple negative breast cancer (TNBC) tumor xenograft and its metastasis to the lungs and lymph nodes by blocking lymphangiogenesis and angiogenesis in pre-metastatic organs as well as primary tumors